Vor Biopharma Inc.
Vor Biopharma Inc.（VOR）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · VOR · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
85
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Vor Biopharma Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
VOR 季度内部人买卖趋势
VOR 内幕交易卖出 · VOR 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · VOR CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
VOR 高管卖出股份 · VOR 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Apr 22, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 165,150 | $2.60M⚡ | Form 4 |
| Apr 17, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 458,411 | $7.46M⚡ | Form 4 |
| Apr 20, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 171,963 | $2.71M⚡ | Form 4 |
| Apr 13, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 530,610 | $8.57M⚡ | Form 4 |
| Apr 14, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 153,735 | $2.46M⚡ | Form 4 |
| Apr 15, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 53,644 | $859K | Form 4 |
| Apr 8, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 353,242 | $5.76M⚡ | Form 4 |
| Apr 8, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 130,862 | $2.21M⚡ | Form 4 |
| Apr 9, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 135,201 | $2.24M⚡ | Form 4 |
| Apr 10, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 828 | $13K | Form 4 |
| Apr 2, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 258,475 | $4.71M⚡ | Form 4 |
| Apr 2, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 1,525 | $29K | Form 4 |
| Apr 6, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 537,754 | $8.88M⚡ | Form 4 |
| Apr 6, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 44,728 | $774K | Form 4 |
| Apr 6, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 6,775 | $125K | Form 4 |
| Dec 18, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Award | 4,625,346 | $50.00M⚡ | Form 4 |
| Dec 5, 2025 | Mahatme Sandesh CFO | Other | 694,137 | — | Form 4 |
| Oct 28, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 87,828 | $2.38M⚡ | Form 4 |
| Oct 28, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 36,483 | $1.03M⚡ | Form 4 |
| Oct 29, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 251,518 | $6.34M⚡ | Form 4 |
| Oct 30, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 24,579 | $617K | Form 4 |
| Oct 23, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 76,880 | $2.15M⚡ | Form 4 |
| Oct 24, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 53,345 | $1.49M⚡ | Form 4 |
| Oct 27, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 90,941 | $2.56M⚡ | Form 4 |
| Oct 20, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 70,366 | $2.08M⚡ | Form 4 |
RA CAPITAL MANAGEMENT, L.P.
Director
日期
Dec 18
股数
4,625,346
均价
$10.81
总金额
$50.00M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 VOR 内幕交易
VOR 内幕交易
Vor Biopharma Inc.（VOR）内幕交易数据来源于公司内部人（包括RA CAPITAL MANAGEMENT, L.P. (Director), Reprogrammed Interchange LLC (10 percent owner), Mahatme Sandesh (CFO)）提交的SEC Form 4申报文件。过去12个月内，3位内部人向SEC提交了交易申报。VOR内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Vor Biopharma Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
VOR 内幕交易 · 5个问题Vor Biopharma Inc.（VOR）的内部人包括高管和董事，如RA CAPITAL MANAGEMENT, L.P. (Director), Reprogrammed Interchange LLC (10 percent owner), Mahatme Sandesh (CFO)等。过去12个月内，3位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026